Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
Volume 0.37M
Average 0.43M
ODTX Account Payables
Amounts the company owes suppliers for goods and services received.
Account Payables history
Currency unavailable · from the balance sheet
No Account Payables data reported for this period type.
Account Payables vs competitors
How ODTX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $14.73M USD | +131.8% | +8.3% | 7.4% | |
ORKAOruka Therapeutics, Inc. | Sep 2026 | $14.38M USD | +551.1% | +131.7% | 1.2% |
ALMSAlumis Inc. Common Stock | Jun 2026 | $12.8M USD | -14.6% | +80.4% | 2.3% |
| Mar 2026 | $10.51M USD | +90.9% | +33.3% | 5.5% | |
| Sep 2026 | $9.47M USD | +26.9% | +136.0% | 0.9% | |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | Sep 2025 | €7.58M EUR | — | — | 4.6% |
| Mar 2026 | $7.52M USD | +22.8% | +11.6% | 2.3% | |
| Jun 2026 | $3.46M USD | +6.5% | +13.6% | 0.4% | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
| Peer median (excluding ODTX) | — | +26.9% | +33.3% | 2.3% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.